Study of Dose Adjustment From Levothyroxine to a New Levothyroxine Sodium Test Formulation
NCT01916304 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 101
Last updated 2015-07-20
Summary
The purpose of this study is to investigate the effect of switching participants taking levothyroxine to a new sodium formulation.
Conditions
Interventions
- DRUG
-
Levothyroxine sodium new formulation
Levothyroxine tablets
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Medical Responsible · Takeda
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-07-31
- Primary Completion
- 2014-06-30
- Completion
- 2014-06-30
Countries
- Belgium
Study Locations
More Related Trials
-
Discontinuation of Levothyroxine Therapy for Patients With Subclinical Hypothyroidism
NCT04288115 ·Status: COMPLETED ·Phase: PHASE4
-
Generic vs. Name-Brand Levothyroxine
NCT00403390 ·Status: COMPLETED ·Phase: NA
-
Patient-centered Dosage of Levothyroxine
NCT06455371 ·Status: RECRUITING ·Phase: NA
-
Long-Term Efficacy and Safety of Once-Weekly Levothyroxine Regimen in Hypothyroid Patients
NCT07133295 ·Status: COMPLETED
-
Improvement of Laboratory Diagnostics in Hypothyroid Patients Using Levothyroxine
NCT06083636 ·Status: RECRUITING
-
Safety and Efficacy of Empiric Levothyroxine (LT4) Dose Increase Versus Individualized LT4 Dose Increase in Hypothyroid Women During Pregnancy
NCT03115515 ·Status: COMPLETED ·Phase: NA
-
Desiccated Thyroid Extract and Levothyroxine for Hypothyroidism Treatment
NCT01739972 ·Status: UNKNOWN ·Phase: NA
-
Dosing of LT4 in Older Individuals
NCT06073665 ·Status: RECRUITING ·Phase: PHASE4
-
Evaluation of the Clinical and Biological Consequences of Levothyrox® Formula Modification
NCT03569800 ·Status: TERMINATED
-
Effects of Levothyroxine Treatment on Hemodynamic and Renal Functions in Subclinical Hypothyroidism
NCT02186405 ·Status: WITHDRAWN ·Phase: PHASE4
-
Combined Replacement Therapy With Levothyroxine and Liothyronine in Thyroidectomized Patients
NCT03053115 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study of XP-8121 For the Treatment of Adult Subjects With Hypothyroidism
NCT05823012 ·Status: COMPLETED ·Phase: PHASE2
-
Thyroid Hormone Replacement for Subclinical Hypothyroidism
NCT01660126 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Levothyroxine Formulation in Hypothyroid Patients With Enteral Feeding
NCT04878614 ·Status: TERMINATED ·Phase: PHASE4
-
Thyroid Hormone Replacement for Subclinical Hypothyroidism and Chronic Heart Failure (ThyroHeart-CHF)
NCT03096613 ·Status: UNKNOWN ·Phase: PHASE4
-
Thyroid Hormone Dose Adjustment in Pregnancy
NCT00230802 ·Status: COMPLETED ·Phase: NA
-
Central Hypothyroidism and Cardiovascular Risk
NCT01574859 ·Status: COMPLETED
-
Interaction Between Levothyroxine and Probiotics in Hypothyroid Patients
NCT03095963 ·Status: COMPLETED ·Phase: NA
-
LT4/LT3 Combination Therapy Versus LT4 Monotherapy in Patients with Autoimmune Hypothyroidism.
NCT05682482 ·Status: RECRUITING ·Phase: PHASE3
-
Effect of Age, Weight and Sex on Levothyroxine Pharmacokinetics
NCT03102177 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
NCT06345339 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Study of Optimal Replacement of Thyroxine in the Elderly
NCT01647750 ·Status: COMPLETED ·Phase: PHASE4
-
Novel Approaches to the Treatment of Hypothyroidism
NCT06731764 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Thyroid Replacement Therapy in Patients With Subclinical Hypothyroidism
NCT04953195 ·Status: UNKNOWN ·Phase: PHASE4
-
Individual Dosing of Levothyroxine After Thyroidectomy
NCT05240911 ·Status: UNKNOWN ·Phase: NA